A recent outcome study of more than 250,000 COVID-19 infected patients found that the histamine receptor blockade significantly improved the outcomes in patients who needed respiratory support and has suggested that this might be due to the ability of famotidine to block the proinflammatory signals arising from H2R activation (Mura et al., 2021). This evidence concerns the gene HRH2 and COVID-19.